| Literature DB >> 32946737 |
Tiziano A Schweizer, Srikanth Mairpady Shambat, Vanina Dengler Haunreiter, Carlos A Mestres, Alberto Weber, Francesco Maisano, Annelies S Zinkernagel, Barbara Hasse.
Abstract
Prosthetic vascular graft infections of the thoracic aorta are rare but can be fatal. Our comparison of collagen- and gelatin-coated grafts showed that collagen-coated grafts were associated with increased biofilm formation and bacterial adherence in vitro and with higher rates of perioperative vascular graft infections in vivo.Entities:
Keywords: Prosthetic vascular graft infection; VASGRA; bacteria; biofilm; coating; collagen-coated; gelatin-coated; polyester
Mesh:
Substances:
Year: 2020 PMID: 32946737 PMCID: PMC7510746 DOI: 10.3201/eid2610.191711
Source DB: PubMed Journal: Emerg Infect Dis ISSN: 1080-6040 Impact factor: 6.883
FigureIncreased susceptibility of collagen graft to biofilm formation compared with gelatin graft. Graft patches were inoculated with indicated bacterial strains for 72 h and analyzed quantitatively and qualitatively. A) Biofilm formation on the graft patches determined by optical density measurements. B) Total biofilm mass volume and maximal biofilm height, respectively, formed on the graft patches by the 3 clinical isolates—SA2, SE1, and EF— determined from the confocal laser scanning microscopy images with imaris software (https://imaris.oxinst.com). C) Adherence assay to the 2 different coatings used by the grafts. The limit of reliable detection of the plate reader is indicated by the dashed line ( OD600nm = 0.1). All data represent mean ± SD of 3 biological replicates performed in at least 2 technical replicates and were analyzed by using GraphPad Prism 8 (GraphPad Software, https://www.graphpad.com). The values above the graphs represent p values, calculated by using 2-way analysis of variance with the Sidak multiple comparison to determine statistical significance between the 2 graft types or coatings (panels A–C). EF, Enterococcus faecalis; OD600nm, optical density at a wavelength of 600; PA, Pseudomonas aeruginosa; PM, Pasteurella multocida; PVGI, prosthetic vascular graft infection; SA, Staphylococcus aureus; SE, S. epidermidis.
Risk for early and late intracavitary thoracic PVGI among cardiac surgery patients with vascular woven polyester grafts coated with collagen or gelatin, Zurich, Switzerland*
| Demographics and risk factors | Early thoracic PVGI, n = 15 | Late thoracic PVGI, n = 13 | Cardiac surgery, no PVGI, n = 384 | p value† |
|---|---|---|---|---|
| Demographic | ||||
| Sex | 0.27 | |||
| M | 3 (20) | 3 (23) | 54 (14) | |
| F | 12 (80) | 10 (77) | 330 (86) | |
| Caucasian race | 15 (100) | 12 (92) | 375 (98) | 0.51 |
| Age, y, median (IQR) | 65 (54–68) | 65 (51–68) | 58 (49–67) | 0.89 |
| Risk factors | ||||
| BMI, kg/m2, median (IQR) | 27 (24–33) | 26 (23–28) | 26 (24–29) | 0.97 |
| Smoking | 0.69 | |||
| Never | 6 (40) | 6 (46) | 150 (39) | |
| Former/current | 9 (60) | 7 (54) | 234 (61) | |
| Alcohol consumption | 4 (27) | 3 (23) | 131 (34.0) | 0.41 |
| Hypertension | 12 (80) | 8 (62) | 273 (72) | 1.0 |
| Diabetes mellitus | 2 (13) | 1 (8) | 54 (14) | 0.78 |
| Dyslipidemia | 7 (47) | 6 (46) | 196 (51) | 0.70 |
| Cardiac events | 8 (53) | 7 (54) | 173 (45) | 0.43 |
| Cerebrovascular events | 3 (20) | 3 (23) | 58 (15) | 0.41 |
| Coagulopathy | 0 (0) | 0 (0) | 4 (1.0) | 1.0 |
| Malignancy, | 4 (27) | 2 (15) | 69 (18) | 0.62 |
| Charlson Comorbidity Index score, median (IQR) | 2 (1–5) | 2 (1–4) | 1 (1–3) | 0.27 |
| Index surgery | 0.55 | |||
| Dissection | 7 (57) | 6 (46) | 154 (40) | |
| Aneurysm/pseudoaneurysm | 8 (53) | 7 (54) | 230 (60) | |
| Symptoms at index operation | 0.004 | |||
| Asymptomatic | 4 (27) | 5 (23) | 223 (58) | |
| Symptomatic | 9 (60) | 10 (77) | 161 (42) | |
| Setting of index operation | 0.08 | |||
| Elective | 9 (60) | 7 (54) | 284 (74) | |
| Urgent/emergency | 6 (40) | 6 (46) | 100 (26) | |
| ASA class at index operation | <0.001 | |||
| Grade | 7 (47) | 3 (23) | 38 (10) | |
| Grade >III | 8 (53) | 10 (77) | 346 (90) | |
| Cardiopulmonary bypass time, min, median (IQR) | 174 (154–338) | 163 (84–363) | 206 (154–338) | 0.23 |
| Polyester vascular woven grafts | 0.005 | |||
| Collagen graft | 11 (74) | 9 (69) | 165 (39.5) | |
| Gelatin graft | 4 (27) | 4 (31) | 219 (52.4) |
|
| PVGI | ||||
| Assumed route | NA | |||
| Perioperative | 15 (100) | 0 | NA | |
| Hematogenous | 0 | 8 (62) | NA | |
| Contiguous | 0 | 5 (38) | NA | |
| Microorganisms | NA | |||
|
| 4 (27) | 3 (23) | NA | |
| Coagulase-negative staphylococci | 2 (13) | 1 (7.7) | NA | |
|
| 0 | 2 (15) | ||
| 4 (27) | 0 | NA | ||
|
| 1 (7) | 2 (15) | NA | |
|
| 1 (7) | 0 | NA | |
|
| 1 (7) | 0 | NA | |
| Culture negative | 2 (14) | 3 (23) | NA |
*Values are no. (%) unless otherwise indicated. ASA, American Society of Anesthesiology; BMI, body mass index; IQR, interquartile range; NA, not applicable; PVGI, prosthetic vascular graft infection. †p values from Fisher exact test (categorical variables) and Wilcoxon rank-sum test (continuous variables) comparing patients with PVGI (early and late combined) and patients without PVGI.